Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Micrografts promote hair growth in androgenetic alopecia treatment.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Antidepressants can cause long-term side effects like severe withdrawal symptoms and sexual dysfunction, which can last for months or years after stopping the medication.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

EtG levels in hair decrease significantly after one month of alcohol abstinence.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.